Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06359015 · ClinicalTrials.gov registry record · Phase 4
Metformin and Esomeprazole in Preterm Pre-eclampsia
A Phase 4 study, sponsored by Christiana Care Health Services.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT06359015: Clinical Trial Phase 4 study, sponsored by Christiana Care Health Services.
NCT06359015 is a Phase 4 study that was terminated before completion, run by Christiana Care Health Services. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06359015, a Phase 4 study, was terminated before completion, sponsored by Christiana Care Health Services.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand diagnosis and treatment of preterm preeclampsia. Currently, there are limited laboratory tests that can be used to diagnosis preeclampsia. Additionally, there are few treatments for this condition. This clinical trial will explore treatment options, Metformin and Esomeprazole, as well as serum markers that could improve the diagnosis and treatment of preterm preeclampsia.
Primary Outcome
sFlt-1 from serum samples
Interventions
- DRUG Metformin
- DRUG Esomeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2025-05-08 |
| Phase | Phase 4 |
Why NCT06359015 stopped before completion
NCT06359015 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT06359015 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06359015 about?
NCT06359015 is a clinical study titled "Metformin and Esomeprazole in Preterm Pre-eclampsia". The purpose of this study is to better understand diagnosis and treatment of preterm preeclampsia. Currently, there are limited laboratory tests that can be used to diagnosis preeclampsia. Additionally, there are few treatments for this condition. This clinical trial will explore treatment options, ...
What is the current status of trial NCT06359015?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2021-02-11. Estimated completion is 2025-05-08.
What interventions are being tested in trial NCT06359015?
The interventions under investigation include: Metformin (DRUG), Esomeprazole (DRUG).
Who is sponsoring clinical trial NCT06359015?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06359015's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI